Meeting Banner
Abstract #1084

Ferumoxytol Dose Optimization for 3D Whole-Heart Congenital Heart Disease Imaging

Sanja Dzelebdzic1, Maher Abadeer1, Gerald Greil1, and Tarique Hussain1
1Cardiac MRI, Children's Medical Center, UT Southwestern, Dallas, TX, United States

Synopsis

Keywords: Heart, Cardiovascular, image quality, ferumoxytol, contrastWith its concomitant ability to shorten the T1 relaxivity of blood and long intravascular half-life, ferumoxytol has become a popular “blood pool” contrast agent. The optimum contrast dose is not known. Reducing the ferumoxytol dose to 2 mg/kg is an efficient method to optimize the image quality, diagnostic performance, and achieve reduction in Gibbs’ truncation artefact.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords